The Art of Strategic Acquisitions

Ben is a corporate transactional attorney who has represented a wide range of public and private companies and many of the leading international private equity sponsors. He has significant experience advising clients on domestic and cross-border M&A, leveraged buyouts, joint ventures, minority investments, divestitures and restructurings. Ben also is an adjunct professor at The Ohio State University Moritz College of Law and serves on the board of NoticeAbility and the advisory board of Calmer Choice.

Dr. Samir Arora attended medical school in Manipal, India. He completed his residency at Hamot Medical Center in Erie, Pennsylvania, where he worked on multiple original research studies.

Since then, Dr. Arora has been a Principal and Sub Investigator involved in Phase I-IV clinical research on over 200 studies, and serves as our primary Clinical Trial Investigator at our Columbus, Ohio location.

He’s conducted studies in the therapeutic areas of hypertension, diabetes, obesity, hyperlipidemia, pain, asthma, COPD, osteoarthritis, vaccines, hormone replacement therapy, smoking cessation, peptic ulcer disease, and contraception. Dr. Arora’s study on breast feeding received national attention and garnered interviews on major networks and newspapers.

Dan is a founding partner of Provariant Equity Partners, a Cleveland OH based equity investor focused on the lower middle market. Prior to Provariant, Dan was a partner with Linsalata Capital Partners, a private equity firm, for 18 years. Prior to that, Dan was with Ernst & Young where he was a Senior Manager providing M&A transaction support services to middle market clients. Dan received a B.S. in accountancy from Miami University, and he earned an M.B.A. with distinction, from Northwestern University. Dan’s responsibilities at Provariant include sourcing and transacting new investment opportunities as well as managing portfolio company oversight. Dan serves on the Board of MWE Holdings, Provariant’s initial stand alone investment.

An Engineer with proven expertise in launching and scaling start-up technology companies, entering new markets, selling & marketing services and well versed in International Business Development. Created startups and managed a successful exit. Specialties: Scaling Start-ups in Technology Services, Unlock potential via M&A, Business Development & Leveraging Global Delivery.

McCormick leads a team responsible for originating, executing and monitoring mezzanine and subordinated debt. He oversees investments supporting clients’ event-driven capital needs, such as acquisitions, buy-out financing, recapitalizations and growth capital. McCormick also manages FNB’s partnerships with other mezzanine and subordinated debt investors for equity co-investment opportunities.

With more than 25 years of financial services experience, McCormick recently served as Managing Director for Huntington Capital Investment Company and prior to that as Principal at Medallion Capital.